{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T15:08:23Z","timestamp":1763737703645,"version":"3.45.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T00:00:00Z","timestamp":1763683200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T00:00:00Z","timestamp":1763683200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Bioinformatics"],"DOI":"10.1186\/s12859-025-06314-x","type":"journal-article","created":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T14:16:10Z","timestamp":1763734570000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["SynergyImage: image-based model for drug combinations synergy score prediction"],"prefix":"10.1186","volume":"26","author":[{"given":"Maryam","family":"Mehrabani","sequence":"first","affiliation":[]},{"given":"Amir","family":"Lakizadeh","sequence":"additional","affiliation":[]},{"given":"Alireza","family":"Fotuhi Siahpirani","sequence":"additional","affiliation":[]},{"given":"Ali","family":"Masoudi-Nejad","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2025,11,21]]},"reference":[{"issue":"4","key":"6314_CR1","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1093\/carcin\/bgt086","volume":"34","author":"K Masui","year":"2013","unstructured":"Masui K, Gini B, Wykosky J, Zanca C, Mischel PS, Furnari FB, et al. A tale of two approaches: complementary mechanisms of cytotoxic and targeted therapy resistance may inform next-generation cancer treatments. Carcinogenesis. 2013;34(4):725\u201338.","journal-title":"Carcinogenesis"},{"issue":"7","key":"6314_CR2","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1038\/nbt.1549","volume":"27","author":"J Leh\u00e1r","year":"2009","unstructured":"Leh\u00e1r J, Krueger AS, Avery W, Heilbut AM, Johansen LM, Price ER, et al. Synergistic drug combinations tend to improve therapeutically relevant selectivity. Nat Biotechnol. 2009;27(7):659\u201366.","journal-title":"Nat Biotechnol"},{"issue":"6","key":"6314_CR3","first-page":"285","volume":"3","author":"S Loewe","year":"1953","unstructured":"Loewe S. The problem of synergism and antagonism of combined drugs. Arzneimittelforschung. 1953;3(6):285\u201390.","journal-title":"Arzneimittelforschung"},{"key":"6314_CR4","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1111\/j.1744-7348.1939.tb06990.x","volume":"26","author":"C Bliss","year":"1939","unstructured":"Bliss C. The toxicity of poisons jointly applied. Ann Appl Biol. 1939;26:585\u2013615.","journal-title":"Ann Appl Biol"},{"issue":"13","key":"6314_CR5","doi-asserted-by":"publisher","first-page":"7977","DOI":"10.1073\/pnas.1337088100","volume":"100","author":"AA Borisy","year":"2003","unstructured":"Borisy AA, Elliott PJ, Hurst NW, Lee MS, Leh\u00e1r J, Price ER, et al. Systematic discovery of multicomponent therapeutics. Proc Natl Acad Sci USA. 2003;100(13):7977\u201382.","journal-title":"Proc Natl Acad Sci USA"},{"key":"6314_CR6","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/j.csbj.2015.09.001","volume":"13","author":"B Yadav","year":"2015","unstructured":"Yadav B, Wennerberg K, Aittokallio T, Tang J. Searching for drug synergy in complex dose\u2013response landscapes using an interaction potency model. Comput Struct Biotechnol J. 2015;13:504\u201313.","journal-title":"Comput Struct Biotechnol J"},{"issue":"10","key":"6314_CR7","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1002\/psp4.12104","volume":"5","author":"MK Morris","year":"2016","unstructured":"Morris MK, Clarke DC, Osimiri LC, Lauffenburger DA. Systematic analysis of quantitative logic model ensembles predicts drug combination effects on cell signaling networks. CPT Pharmacomet Syst Pharmacol. 2016;5(10):544\u201353.","journal-title":"CPT Pharmacomet Syst Pharmacol"},{"issue":"3","key":"6314_CR8","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1007\/s11831-021-09617-3","volume":"29","author":"V Kumar","year":"2022","unstructured":"Kumar V, Dogra N. A comprehensive review on deep synergistic drug prediction techniques for cancer. Arch Comput Methods Eng. 2022;29(3):1443\u201361.","journal-title":"Arch Comput Methods Eng"},{"issue":"9","key":"6314_CR9","doi-asserted-by":"publisher","first-page":"1538","DOI":"10.1093\/bioinformatics\/btx806","volume":"34","author":"K Preuer","year":"2018","unstructured":"Preuer K, Lewis RP, Hochreiter S, Bender A, Bulusu KC, Klambauer G. Deepsynergy: predicting anti-cancer drug synergy with deep learning. Bioinformatics. 2018;34(9):1538\u201346.","journal-title":"Bioinformatics"},{"issue":"6","key":"6314_CR10","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1158\/1535-7163.MCT-15-0843","volume":"15","author":"J O'Neil","year":"2016","unstructured":"O\u2019Neil J, Benita Y, Feldman I, Chenard M, Roberts B, Liu Y, et al. An unbiased oncology compound screen to identify novel combination strategies. Mol Cancer Ther. 2016;15(6):1155\u201362.","journal-title":"Mol Cancer Ther"},{"issue":"2","key":"6314_CR11","doi-asserted-by":"publisher","first-page":"bbab587","DOI":"10.1093\/bib\/bbab587","volume":"23","author":"X Wang","year":"2022","unstructured":"Wang X, Zhu H, Jiang Y, Li Y, Tang C, Chen X, et al. PRODeepSyn: predicting anticancer synergistic drug combinations by embedding cell lines with protein\u2013protein interaction network. Brief Bioinform. 2022;23(2):bbab587.","journal-title":"Brief Bioinform"},{"issue":"2","key":"6314_CR12","doi-asserted-by":"publisher","first-page":"e1008653","DOI":"10.1371\/journal.pcbi.1008653","volume":"17","author":"Q Liu","year":"2021","unstructured":"Liu Q, Xie L. TranSynergy: mechanism-driven interpretable deep neural network for the synergistic prediction and pathway deconvolution of drug combinations. PLoS Comput Biol. 2021;17(2):e1008653.","journal-title":"PLoS Comput Biol"},{"key":"6314_CR13","doi-asserted-by":"publisher","DOI":"10.1007\/s12539-023-00596-6","author":"S Yan","year":"2024","unstructured":"Yan S, Zheng D. A deep neural network for predicting synergistic drug combinations on cancer. Interdiscip Sci Comput Life Sci. 2024. https:\/\/doi.org\/10.1007\/s12539-023-00596-6.","journal-title":"Interdiscip Sci Comput Life Sci"},{"issue":"7","key":"6314_CR14","doi-asserted-by":"publisher","first-page":"2577","DOI":"10.1021\/acs.jcim.3c01486","volume":"64","author":"F Rafiei","year":"2024","unstructured":"Rafiei F, Zeraati H, Abbasi K, Razzaghi P, Ghasemi JB, Parsaeian M, et al. Cfssynergy: combining feature-based and similarity-based methods for drug synergy prediction. J Chem Inf Model. 2024;64(7):2577\u201385.","journal-title":"J Chem Inf Model"},{"issue":"1","key":"6314_CR15","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s13321-024-00839-8","volume":"16","author":"X Zhao","year":"2024","unstructured":"Zhao X, Xu J, Shui Y, Xu M, Hu J, Liu X, et al. PermuteDDS: a permutable feature fusion network for drug-drug synergy prediction. J Cheminform. 2024;16(1):41.","journal-title":"J Cheminform"},{"key":"6314_CR16","doi-asserted-by":"publisher","first-page":"108054","DOI":"10.1016\/j.compbiolchem.2024.108054","volume":"110","author":"X Huangfu","year":"2024","unstructured":"Huangfu X, Zhang C, Li H, Li S, Li Y. Snsynergy: Similarity network-based machine learning framework for synergy prediction towards new cell lines and new anticancer drug combinations. Comput Biol Chem. 2024;110:108054.","journal-title":"Comput Biol Chem"},{"issue":"11","key":"6314_CR17","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1038\/s42256-022-00557-6","volume":"4","author":"X Zeng","year":"2022","unstructured":"Zeng X, Xiang H, Yu L, Wang J, Li K, Nussinov R, et al. Accurate prediction of molecular properties and drug targets using a self-supervised image representation learning framework. Nat Mach Intell. 2022;4(11):1004\u201316.","journal-title":"Nat Mach Intell"},{"issue":"1","key":"6314_CR18","doi-asserted-by":"publisher","first-page":"11399","DOI":"10.1038\/s41598-019-47765-6","volume":"9","author":"A Sharma","year":"2019","unstructured":"Sharma A, Vans E, Shigemizu D, Boroevich KA, Tsunoda T. Deepinsight: a methodology to transform a non-image data to an image for convolution neural network architecture. Sci Rep. 2019;9(1):11399.","journal-title":"Sci Rep"},{"key":"6314_CR19","doi-asserted-by":"crossref","unstructured":"He K, Zhang X, Ren S, Sun J. Deep residual learning for image recognition. In: Proceedings of the IEEE conference on computer vision and pattern recognition. 2016. pp. 770\u2013778.","DOI":"10.1109\/CVPR.2016.90"},{"key":"6314_CR20","doi-asserted-by":"crossref","unstructured":"Noroozi M, Favaro P. Unsupervised learning of visual representations by solving jigsaw puzzles. In: European conference on computer vision. Springer; 2016. pp. 69\u201384.","DOI":"10.1007\/978-3-319-46466-4_5"},{"issue":"6","key":"6314_CR21","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1016\/j.cell.2017.10.049","volume":"171","author":"A Subramanian","year":"2017","unstructured":"Subramanian A, Narayan R, Corsello SM, Peck DD, Natoli TE, Lu X, et al. A next generation connectivity map: L1000 platform and the first 1,000,000 profiles. Cell. 2017;171(6):1437-1452.e1417.","journal-title":"Cell"},{"issue":"W1","key":"6314_CR22","doi-asserted-by":"publisher","first-page":"W43","DOI":"10.1093\/nar\/gkz337","volume":"47","author":"B Zagidullin","year":"2019","unstructured":"Zagidullin B, Aldahdooh J, Zheng S, Wang W, Wang Y, Saad J, et al. DrugComb: an integrative cancer drug combination data portal. Nucleic Acids Res. 2019;47(W1):W43\u201351.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"6314_CR23","doi-asserted-by":"publisher","first-page":"bbab390","DOI":"10.1093\/bib\/bbab390","volume":"23","author":"J Wang","year":"2022","unstructured":"Wang J, Liu X, Shen S, Deng L, Liu H. DeepDDS: deep graph neural network with attention mechanism to predict synergistic drug combinations. Brief Bioinform. 2022;23(1):bbab390.","journal-title":"Brief Bioinform"},{"issue":"5","key":"6314_CR24","doi-asserted-by":"publisher","first-page":"e1006752","DOI":"10.1371\/journal.pcbi.1006752","volume":"15","author":"A Malyutina","year":"2019","unstructured":"Malyutina A, Majumder MM, Wang W, Pessia A, Heckman CA, Tang J. Drug combination sensitivity scoring facilitates the discovery of synergistic and efficacious drug combinations in cancer. PLoS Comput Biol. 2019;15(5):e1006752.","journal-title":"PLoS Comput Biol"},{"issue":"8","key":"6314_CR25","doi-asserted-by":"publisher","first-page":"e1004426","DOI":"10.1371\/journal.pcbi.1004426","volume":"11","author":"\u00c5 Flobak","year":"2015","unstructured":"Flobak \u00c5, Baudot A, Remy E, Thommesen L, Thieffry D, Kuiper M, et al. Discovery of drug synergies in gastric cancer cells predicted by logical modeling. PLoS Comput Biol. 2015;11(8):e1004426.","journal-title":"PLoS Comput Biol"},{"issue":"13","key":"6314_CR26","doi-asserted-by":"publisher","first-page":"3564","DOI":"10.1158\/0008-5472.CAN-17-0489","volume":"77","author":"SL Holbeck","year":"2017","unstructured":"Holbeck SL, Camalier R, Crowell JA, Govindharajulu JP, Hollingshead M, Anderson LW, et al. The National Cancer Institute ALMANAC: a comprehensive screening resource for the detection of anticancer drug pairs with enhanced therapeutic activity. Cancer Res. 2017;77(13):3564\u201376.","journal-title":"Cancer Res"},{"issue":"10","key":"6314_CR27","doi-asserted-by":"publisher","first-page":"btae604","DOI":"10.1093\/bioinformatics\/btae604","volume":"40","author":"X Li","year":"2024","unstructured":"Li X, Shen B, Feng F, Li K, Tang Z, Ma L, et al. Dual-view jointly learning improves personalized drug synergy prediction. Bioinformatics. 2024;40(10):btae604.","journal-title":"Bioinformatics"},{"issue":"4","key":"6314_CR28","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.1007\/s10876-021-02101-9","volume":"33","author":"E Akbari","year":"2022","unstructured":"Akbari E, Mousazadeh H, Hanifehpour Y, Mostafavi E, Gorabi AM, Nejati K, et al. Co-loading of cisplatin and methotrexate in nanoparticle-based PCL-PEG system enhances lung cancer chemotherapy effects. J Cluster Sci. 2022;33(4):1751\u201362.","journal-title":"J Cluster Sci"},{"key":"6314_CR29","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1007\/s10495-015-1158-5","volume":"20","author":"JS-S Soo","year":"2015","unstructured":"Soo JS-S, Ng C-H, Tan SH, Malik RA, Teh Y-C, Tan B-S, et al. Metformin synergizes 5-fluorouracil, epirubicin, and cyclophosphamide (FEC) combination therapy through impairing intracellular ATP production and DNA repair in breast cancer stem cells. Apoptosis. 2015;20:1373\u201387.","journal-title":"Apoptosis"},{"issue":"3","key":"6314_CR30","doi-asserted-by":"publisher","first-page":"e151","DOI":"10.1016\/j.clbc.2022.12.008","volume":"23","author":"R Lobefaro","year":"2023","unstructured":"Lobefaro R, Mariani L, Peverelli G, Ligorio F, Fuc\u00e0 G, Rametta A, et al. Efficacy and safety of first-line carboplatin-paclitaxel and carboplatin-gemcitabine in patients with advanced triple-negative breast cancer: a monocentric, retrospective comparison. Clin Breast Cancer. 2023;23(3):e151\u201362.","journal-title":"Clin Breast Cancer"},{"key":"6314_CR31","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1007\/PL00006740","volume":"45","author":"TT Aung","year":"2000","unstructured":"Aung TT, Davis MA, Ensminger WD, Lawrence TS. Interaction between gemcitabine and mitomycin-C in vitro. Cancer Chemother Pharmacol. 2000;45:38\u201342.","journal-title":"Cancer Chemother Pharmacol"},{"key":"6314_CR32","first-page":"100162","volume":"22","author":"V Ernani","year":"2020","unstructured":"Ernani V, Jahan R, Smith LM, Marr AS, Kimbrough SE, Kos ME, et al. A phase I study of weekly doxorubicin and oral topotecan for patients with relapsed or refractory small cell lung cancer (SCLC): a Fred and Pamela buffet cancer center clinical trials network study. Cancer Treat Res Commun. 2020;22:100162.","journal-title":"Cancer Treat Res Commun"},{"issue":"3B","key":"6314_CR33","first-page":"2425","volume":"26","author":"M Zampino","year":"2006","unstructured":"Zampino M, Lorizzo K, Rocca A, Locatelli M, Zorzino L, Manzoni S, et al. Oxaliplatin combined with 5-fluorouracil and methotrexate in advanced colorectal cancer. Anticancer Res. 2006;26(3B):2425\u20138.","journal-title":"Anticancer Res"},{"key":"6314_CR34","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.critrevonc.2016.03.014","volume":"102","author":"GY Ho","year":"2016","unstructured":"Ho GY, Woodward N, Coward JI. Cisplatin versus carboplatin: comparative review of therapeutic management in solid malignancies. Crit Rev Oncol Hematol. 2016;102:37\u201346.","journal-title":"Crit Rev Oncol Hematol"},{"key":"6314_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.crmeth.2024.100865","author":"Y Yang","year":"2024","unstructured":"Yang Y, Qiu Y, Hu J, Rosen-Zvi M, Guan Q, Cheng F. A deep learning framework combining molecular image and protein structural representations identifies candidate drugs for pain. Cell Rep Methods. 2024. https:\/\/doi.org\/10.1016\/j.crmeth.2024.100865.","journal-title":"Cell Rep Methods"},{"key":"6314_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.cancergen.2025.02.004","author":"D Kawahara","year":"2025","unstructured":"Kawahara D, Kishi M, Kadooka Y, Hirose K, Murakami Y. Integrating radiomics and gene expression by mapping on the image with improved DeepInsight for clear cell renal cell carcinoma. Cancer Genet. 2025. https:\/\/doi.org\/10.1016\/j.cancergen.2025.02.004.","journal-title":"Cancer Genet"},{"issue":"1","key":"6314_CR37","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1093\/jamia\/ocaa212","volume":"28","author":"Y Kim","year":"2021","unstructured":"Kim Y, Zheng S, Tang J, Jim Zheng W, Li Z, Jiang X. Anticancer drug synergy prediction in understudied tissues using transfer learning. J Am Med Inform Assoc. 2021;28(1):42\u201351.","journal-title":"J Am Med Inform Assoc"}],"container-title":["BMC Bioinformatics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12859-025-06314-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12859-025-06314-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12859-025-06314-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T14:16:11Z","timestamp":1763734571000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcbioinformatics.biomedcentral.com\/articles\/10.1186\/s12859-025-06314-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,21]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["6314"],"URL":"https:\/\/doi.org\/10.1186\/s12859-025-06314-x","relation":{},"ISSN":["1471-2105"],"issn-type":[{"value":"1471-2105","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,21]]},"assertion":[{"value":"21 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This article does not involve any new studies of human or animal subjects performed by any of the authors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"This article does not contain any personal data in any form.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"283"}}